These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2575808)

  • 41. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
    Wilkins RC; Ng CE; Raaphorst GP
    Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of B16 melanoma cells exposed in vitro to long-term IFN-alpha treatment (B16alpha cells) as a tumor vaccine in mice.
    Wu TY; Fleischmann WR
    J Interferon Cytokine Res; 1998 Oct; 18(10):829-39. PubMed ID: 9809618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian small cell tumors: an electron microscopic review.
    Dickersin GR; Scully RE
    Ultrastruct Pathol; 1998; 22(3):199-226. PubMed ID: 9793201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant melanoma of the nictitating membrane in a cat (Felis vulgaris).
    Roels S; Ducatelle R
    J Comp Pathol; 1998 Aug; 119(2):189-93. PubMed ID: 9749364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model.
    Scott GA; Cassidy L
    J Invest Dermatol; 1998 Aug; 111(2):243-50. PubMed ID: 9699725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A.
    Martinetti A; Seregni E; Belli F; Mazzocchi A; Agresti R; Cascinelli N; Greco M; Bombardieri E
    Anticancer Res; 1998; 18(3B):2027-30. PubMed ID: 9677461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.
    Mordoh J; Kairiyama C; Bover L; Solarolo E
    Medicina (B Aires); 1997; 57(4):421-7. PubMed ID: 9674264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma.
    Brobeil A; Berman C; Cruse CW; De Conti R; Cantor A; Lyman GH; Joseph E; Rapaport D; Wells K; Reintgen DS
    Ann Surg Oncol; 1998 Jun; 5(4):376-83. PubMed ID: 9641461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of a motility factor by a newly established lung adenocarcinoma cell line.
    Klominek J; Robért KH; Bergh J; Hjerpe A; Gahrton G; Sundqvist KG
    Anticancer Res; 1998; 18(2A):759-67. PubMed ID: 9615717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colon adenocarcinoma and B-16 melanoma grow larger following laparotomy vs. pneumoperitoneum in a murine model.
    Southall JC; Lee SW; Allendorf JD; Bessler M; Whelan RL
    Dis Colon Rectum; 1998 May; 41(5):564-9. PubMed ID: 9593237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative importance of quantifying area and vascular patterns in uveal melanomas.
    Mehaffey MG; Folberg R; Meyer M; Bentler SE; Hwang T; Woolson R; Moore KC
    Am J Ophthalmol; 1997 Jun; 123(6):798-809. PubMed ID: 9535624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies.
    Filshie RJ; Zannettino AC; Makrynikola V; Gronthos S; Henniker AJ; Bendall LJ; Gottlieb DJ; Simmons PJ; Bradstock KF
    Leukemia; 1998 Mar; 12(3):414-21. PubMed ID: 9529137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
    Gould SW; Banwell PE; Rosin RD
    Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV): growth modulation of human tumor cell lines in agar.
    Wesseling B; Kopelovich L
    Anticancer Res; 1997; 17(4A):2599-602. PubMed ID: 9252687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
    Zewe M; Rybak SM; Dübel S; Coy JF; Welschof M; Newton DL; Little M
    Immunotechnology; 1997 Jun; 3(2):127-36. PubMed ID: 9237097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitizing T-lymphocytes for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanoma.
    Lipshy KA; Kostuchenko PJ; Hamad GG; Bland CE; Barrett SK; Bear HD
    Ann Surg Oncol; 1997 Jun; 4(4):334-41. PubMed ID: 9181234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and activity of partial retro-inverso analogs of the antimetastatic laminin-derived peptide, YIGSR-NH2.
    Zhao M; Kleinman HK; Mokotoff M
    J Pept Res; 1997 Mar; 49(3):240-53. PubMed ID: 9151257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
    Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
    Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.
    Saitoh S; Kurisaka M; Mori K; Maeda N; Fujimoto S
    Jpn J Cancer Res; 1997 Mar; 88(3):289-95. PubMed ID: 9140114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.